Symmetry Peak Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Symmetry Peak Management's XBI Position: Q4 2017 in Review
Symmetry Peak Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 6,000 shares — an estimated $519K sold.
Symmetry Peak Management first reported a position in XBI in Q3 2017 and held it in 1 quarter. The position peaked at $519K in Q3 2017. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.
- Symmetry Peak Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
- Symmetry Peak Management sold 6,000 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $519K.
- Symmetry Peak Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and held it in 1 quarter.
- Symmetry Peak Management's State Street SPDR S&P Biotech ETF position peaked at $519K in Q3 2017.
- 397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.
Based on Symmetry Peak Management's 13F filing for Q4 2017, filed 15 Feb 2018.